Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
European Journal of Neurology|June 17, 2005
Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosisM Zorzon, R Zivadinov, L Locatelli, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 28, 2007
Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophyR Zivadinov, L Locatelli, D Cookfair, et al.Scandinavian Journal of Gastroenterology|September 1, 1996
Clinical findings in a family with familial adenomatous polyposis and a missense mutation of the adenomatous polyposis coli geneC A Marchese, F Bertolino, B Ceccopieri, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2003
Correlation of sexual dysfunction and brain magnetic resonance imaging in multiple sclerosisM Zorzon, R Zivadinov, L Locatelli, et al.Cell Death & Disease|October 19, 2013
Constitutive localization of DR4 in lipid rafts is mandatory for TRAIL-induced apoptosis in B-cell hematologic malignanciesM Marconi, B Ascione, L Ciarlo, et al.Journal of Environmental Management|January 1, 2026
Simulating climate change impacts on soil carbon storage in agroecosystems from Brazilian drylandsLucas T Greschuk, Stephen Ogle, Jorge L Locatelli, et al.International Journal of Cancer|May 29, 2014
YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulationMarzia Pennati, Stefania Sbarra, Michelandrea De Cesare, et al.Anticancer Research|January 30, 2022
The Natural Estrogen Receptor Beta Agonist Silibinin as a Promising Therapeutic Tool in Diffuse Large B-cell LymphomaElena Ortona, Silvia L Locatelli, Maria Teresa Pagano, et al.Oncotarget|January 5, 2017
Estrogen receptor β ligation inhibits Hodgkin lymphoma growth by inducing autophagyMarina Pierdominici, Angela Maselli, Silvia L Locatelli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530Silvia L Locatelli, Giuseppa Careddu, Simone Serio, et al.Pageof 7